SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-088220
Filing Date
2021-07-01
Accepted
2021-07-01 16:02:36
Documents
11
Period of Report
2021-07-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2120284d1_8k.htm 8-K 31285
2 EXHIBIT 10.1 tm2120284d1_ex10-1.htm EX-10.1 74470
3 EXHIBIT 10.2 tm2120284d1_ex10-2.htm EX-10.2 76126
4 EXHIBIT 10.3 tm2120284d1_ex10-3.htm EX-10.3 73985
5 EXHIBIT 10.4 tm2120284d1_ex10-4.htm EX-10.4 74850
6 EXHIBIT 10.5 tm2120284d1_ex10-5.htm EX-10.5 75652
7 EXHIBIT 10.6 tm2120284d1_ex10-6.htm EX-10.6 79450
8 EXHIBIT 10.7 tm2120284d1_ex10-7.htm EX-10.7 78833
9 EXHIBIT 10.8 tm2120284d1_ex10-8.htm EX-10.8 75910
10 EXHIBIT 10.9 tm2120284d1_ex10-9.htm EX-10.9 74622
11 EXHIBIT 10.10 tm2120284d1_ex10-10.htm EX-10.10 73845
  Complete submission text file 0001104659-21-088220.txt   790473
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 211065814
SIC: 2835 In Vitro & In Vivo Diagnostic Substances